Deep RNA sequencing of intensive care unit patients with COVID-19

[1]  S. Arora,et al.  Faculty Opinions recommendation of Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  R. Kennedy,et al.  SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates , 2020, The Lancet.

[3]  M. Cho,et al.  A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19 , 2020, EBioMedicine.

[4]  J. Rello,et al.  Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All , 2020, Infectious Diseases and Therapy.

[5]  N. Ojeda,et al.  HLA genetic polymorphisms and prognosis of patients with COVID-19 , 2020, Medicina Intensiva (English Edition).

[6]  T. Rice,et al.  Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic. , 2020, JAMA.

[7]  A. Koohpaei,et al.  Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU , 2020, BMC Infectious Diseases.

[8]  J. Timsit,et al.  Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome , 2020, Journal of Clinical Immunology.

[9]  I. Amit,et al.  Deciphering the state of immune silence in fatal COVID-19 patients , 2020, Nature Communications.

[10]  M. Libra,et al.  Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? , 2020, Cancers.

[11]  L. Ren,et al.  Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.

[12]  A. Gasbarrini,et al.  Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients , 2020, British journal of haematology.

[13]  Nicolas Carlier,et al.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.

[14]  Lee-Jen Wei,et al.  Remdesivir for the Treatment of Covid-19 - Preliminary Report. , 2020, The New England journal of medicine.

[15]  E. Robilotti,et al.  Determinants of COVID-19 disease severity in patients with cancer , 2020, Nature Medicine.

[16]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[17]  D. Matthews,et al.  Neuropilin-1 is a host factor for SARS-CoV-2 infection , 2020, Science.

[18]  D. Leaf,et al.  COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.

[19]  P. Hsueh,et al.  Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? , 2020, Journal of Microbiology, Immunology and Infection.

[20]  L. Dodd,et al.  Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.

[21]  J. Rotter,et al.  Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[22]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[23]  Ji He,et al.  Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19) , 2020, HLA.

[24]  M. Schwartz,et al.  The coding capacity of SARS-CoV-2 , 2020, Nature.

[25]  Akihide Ryo,et al.  Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.

[26]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[27]  F. Kirchhoff,et al.  Cellular Factors Targeting HIV-1 Transcription and Viral RNA Transcripts , 2020, Viruses.

[28]  T. C. I. team.  Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States , 2020 .

[29]  Catherine M. Brown,et al.  Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States , 2020, Nature Medicine.

[30]  Q. Fan,et al.  D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19 , 2020, Journal of Thrombosis and Haemostasis.

[31]  Xin Li,et al.  COVID-19 with Different Severities: A Multicenter Study of Clinical Features , 2020, American journal of respiratory and critical care medicine.

[32]  Wenhong Zhang,et al.  Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients , 2020, Journal of Infection.

[33]  W. Fairbrother,et al.  Alternative RNA splicing and alternative transcription start/end in acute respiratory distress syndrome , 2020, Intensive Care Medicine.

[34]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[35]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[36]  Feng Li,et al.  Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity , 2020, Emerging microbes & infections.

[37]  Jennifer Lu,et al.  Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.

[38]  Jean Thierry-Mieg,et al.  Magic-BLAST, an accurate RNA-seq aligner for long and short reads , 2019, BMC Bioinformatics.

[39]  Osamu Takeuchi,et al.  N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation , 2019, Nature Microbiology.

[40]  S. Fesik,et al.  Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity , 2019, Cell reports.

[41]  Robert J. Weatheritt,et al.  Efficient and Accurate Quantitative Profiling of Alternative Splicing Patterns of Any Complexity on a Laptop. , 2018, Molecular cell.

[42]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[43]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[44]  David P. Kreil,et al.  A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control consortium , 2014, Nature Biotechnology.

[45]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[46]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[47]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[48]  Arthur S Slutsky,et al.  Erratum to: The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[49]  Richard Beale,et al.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[50]  A. Towbin,et al.  Chronic granulomatous disease , 2010, Pediatric Radiology.

[51]  Michael W Pfaffl,et al.  RNA integrity and the effect on the real-time qRT-PCR performance. , 2006, Molecular aspects of medicine.

[52]  M. Klagsbrun,et al.  Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. , 2000, Genomics.